Equities

Wai Chun Bio Technology Ltd

Wai Chun Bio Technology Ltd

Actions
  • Price (HKD)0.074
  • Today's Change0.00 / 0.00%
  • Shares traded389.40k
  • 1 Year change-56.47%
  • Beta--
Data delayed at least 15 minutes, as of Sep 30 2024 08:48 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Jun 30 2023202320222020
ASSETS
Cash And Short Term Investments6.317.525.45
Total Receivables, Net425114
Total Inventory809470
Prepaid expenses00.100.10
Other current assets, total0.630.750.74
Total current assets12915390
Property, plant & equipment, net1119798
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets240250188
LIABILITIES
Accounts payable644443
Accrued expenses211315
Notes payable/short-term debt628475
Current portion long-term debt/capital leases1.671.283.59
Other current liabilities, total113614
Total current liabilities159178150
Total long term debt716651
Total debt134151130
Deferred income tax------
Minority interest464425
Other liabilities, total------
Total liabilities275288226
SHAREHOLDERS EQUITY
Common stock434241
Additional paid-in capital210210210
Retained earnings (accumulated deficit)(296)(323)(311)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total8.283322
Total equity(35)(38)(37)
Total liabilities & shareholders' equity240250188
Total common shares outstanding171168166
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.